Review
Cell Biology
Ganyi Chen, Hongwei Jiang, Yiwei Yao, Zhonghao Tao, Wen Chen, Fuhua Huang, Xin Chen
Summary: Macrophages play a crucial role in cardiomyopathy and understanding their molecular mechanisms helps in understanding the development of the disease. Targeted therapy on macrophages has shown promise in experimental studies, but there are challenges and considerations for clinical translation.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
(2022)
Review
Pharmacology & Pharmacy
Kai Liang, Jian-Ye Dai
Summary: This article introduces potential drug targets in lipid metabolism and summarizes recent research progress. The role of lipid metabolism in obesity and other metabolic diseases has received much attention, and it also has a significant impact on the growth of cancer cells.
FRONTIERS IN PHARMACOLOGY
(2022)
Article
Engineering, Biomedical
Junhee Choi, Junsun Hwang, Jin-young Kim, Hongsoo Choi
Summary: Magnetically actuated microrobots have made significant progress in targeted therapeutic delivery, offering unique advantages in accessing hard-to-reach lesions in a minimally invasive manner. However, challenges such as low survival rate of transplanted cells and difficulties with administration route remain to be addressed for further advancements in the field.
ADVANCED HEALTHCARE MATERIALS
(2021)
Review
Immunology
Lina S. M. Huang, Evan Y. Snyder, Robert T. Schooley
Summary: AIDS caused by HIV-1 has been a global public health challenge for decades. While drugs targeting CCR5-mediated entry or HIV-1 replication have been used clinically, drugs targeting CXCR4 have not yet reached clinical application. Research is ongoing on discovering novel molecules targeting CXCR4 for potential future anti-HIV therapeutic development.
CLINICAL INFECTIOUS DISEASES
(2021)
Review
Pharmacology & Pharmacy
Chuchu Xu, Yian Chen, Qinghong Yu, Jiaqing Song, Ying Jin, Xiufei Gao
Summary: This comprehensive review examines the compounds that target ferroptosis in breast cancer and elucidates their potential mechanisms of action. It also discusses the challenges associated with the clinical application of ferroptosis-inducing drugs, providing valuable insights for the development of novel treatment strategies for breast cancer.
FRONTIERS IN PHARMACOLOGY
(2023)
Review
Biotechnology & Applied Microbiology
Lam Chung Liang, Nadiah Sulaiman, Muhammad Dain Yazid
Summary: Duchenne muscular dystrophy (DMD) is a severe form of muscle dystrophy that currently lacks effective treatment options. Gene therapy has been proposed as a potential solution, but it also faces limitations and challenges.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY
(2022)
Article
Chemistry, Medicinal
Chao Wang, Yujing Zhang, Jie Wang, Dongming Xing
Summary: PROTACs are a novel drug discovery paradigm that utilizes the protein degradation pathway for target degradation, with VHL-based PROTACs emerging as a promising approach for treating diseases that are difficult to be dealt with by conventional methods. Advances in VHL-based PROTACs have been summarized in this review, highlighting the opportunities and challenges in this area.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
(2022)
Review
Chemistry, Multidisciplinary
Jieyu Yuhan, Liye Zhu, Longjiao Zhu, Kunlun Huang, Xiaoyun He, Wentao Xu
Summary: Cell-specific aptamers are a promising approach in disease therapy, with research progress in classification, modification, and application. They target cell surface markers, intracellular components, and extracellular components, with advances in stability, affinity, and application to improve cellular microenvironments for successful disease therapy.
JOURNAL OF CONTROLLED RELEASE
(2022)
Review
Medicine, Research & Experimental
Ashish Ranjan Sharma, Manojit Bhattacharya, Swarnav Bhakta, Abinit Saha, Sang-Soo Lee, Chiranjib Chakraborty
Summary: Circular RNAs, a novel family of RNAs, play important roles in cellular physiology and disease progression, characterized by structural stability, conservation, and high abundance in the cell.
MOLECULAR THERAPY-NUCLEIC ACIDS
(2021)
Review
Pharmacology & Pharmacy
Wei-Jian Ni, Hao Lu, Nan-Nan Ma, Bing-Bing Hou, Jing Zeng, Hong Zhou, Wei Shao, Xiao-Ming Meng
Summary: This review comprehensively discusses the crucial roles of N-6-methyladenosine (m(6)A), the most common RNA modification, in kidney diseases. It also explores the possibilities and relevance of using m(6)A as a target for epigenetic therapy and provides a detailed description of the specific alterations in loci associated with cellular processes related to kidney diseases.
BRITISH JOURNAL OF PHARMACOLOGY
(2023)
Review
Immunology
Ke Wang, Tangyou Mao, Xinyu Lu, Muyuan Wang, Yifei Yun, Zeyu Jia, Lei Shi, Haoxi Jiang, Junxiang Li, Rui Shi
Summary: Ulcerative colitis (UC) is a recurring and incurable inflammatory bowel disease that causes great suffering and economic burden for patients due to limited treatment options. This review highlights the importance of macrophage polarization in the development of UC and explores the potential of natural substances to target macrophage phenotype and elucidate the mechanism for its treatment. These findings may provide novel directions and references for the clinical management of UC.
FRONTIERS IN IMMUNOLOGY
(2023)
Review
Pharmacology & Pharmacy
Yixin Lv, Zhoudong Zhang, Sheng Tian, Weipeng Wang, Huanqiu Li
Summary: FUTs play significant roles in cancer development, contributing to abnormal events such as uncontrolled cell proliferation, invasion, angiogenesis, metastasis, immune evasion, and therapy resistance. They have become attractive therapeutic targets for solid cancers, and many substrate analogs have been discovered as potential FUT inhibitors. The development of FUT protein structures has also advanced the design of nonsubstrate-based FUT inhibitors.
DRUG DISCOVERY TODAY
(2023)
Review
Cell & Tissue Engineering
Pinyan Liu, Yongcui Mao, Ye Xie, Jiayun Wei, Jia Yao
Summary: This review summarizes the published clinical trials of stem cells for the treatment of liver fibrosis/cirrhosis and provides an overview of various cell sources, cell doses, and delivery methods. The molecular mechanisms of how stem cells play a therapeutic role in liver fibrosis and the prospects of future clinical implementation of stem cells are also discussed.
STEM CELL RESEARCH & THERAPY
(2022)
Review
Chemistry, Medicinal
Xinchen Lu, Jinmei Jin, Ye Wu, Xiaoxia Liu, Xiaohui Liang, Jiayi Lin, Qingyan Sun, Jiangjiang Qin, Weidong Zhang, Xin Luan
Summary: This review discusses the critical role of RAS gene mutations in fatal cancers and explores the potential of PROTAC strategy as a powerful tool for handling undruggable targets. PROTAC is expected to become a feasible strategy to overcome the bottleneck of classical RAS inhibitors.
MEDICINAL RESEARCH REVIEWS
(2023)
Review
Pharmacology & Pharmacy
Claudia Ceci, Pedro Miguel Lacal, Grazia Graziani
Summary: Antibody-drug conjugates (ADCs) are a new group of anticancer agents that combine the selectivity of monoclonal antibodies with the cell killing properties of chemotherapeutic agents. However, the development of ADCs faces challenges such as low tumor selectivity, premature release of drugs, and tumor resistance mechanisms. The design of inert antibodies and the discovery of innovative targets and drugs have led to the development of next-generation ADCs with improved therapeutic properties.
PHARMACOLOGY & THERAPEUTICS
(2022)